WELCOME TO

Specialist Communications for Life Sciences
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:
PR & Media
- Press releases
- Article writing and placement
- Media interviews
- Messaging
- Copy writing
- Social media
- Media training
- Events
Marketing
- Conference, event and trade show support
- Marketing literature
- Market research
- Campaign development
- Advertising
- Sponsorship
- Product launches
Design & Branding
- Website design and development
- Print collateral development
- Identity and logo creation
- Brand strategy
- Presentation development
- Video production
Investor Relations
- Business plan development
- Presentation development
- PR targeting the life science trade press read by investors

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
PEGS Boston
-
ASGCT Annual Meeting 2026
-
BioBeat 2026
-
SLAS Europe 2026
Lab Thread introduces Unified Lab Software Platform to streamline biological research
Connects scientific teams, data and workflows within a single, fully integrated digital lab management system Silverstone, UK, 30 April 2026: Lab Thread Ltd, a UK-based life science software company, today [...]
EpilepsyGTx appoints Professor Dimitri Kullmann as Chief Scientific Officer
Appointment of UCL Neurologist will accelerate the delivery of novel gene therapies for refractory epilepsy London, UK, 29 APRIL 2026: EpilepsyGTx, a biotechnology company focused on research and development of [...]
Bio-Rad Launches PTC Harmony 96 and PTC Harmony Deepwell Thermal Cyclers
New PTC Harmony Thermal Cycler Line Expands Access to Reliable, High-Performance PCR Across Academic and Biopharma Laboratories HERCULES, Calif.—April 28, 2026—Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader [...]






















